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Introduction 
Elimination of plasmids that carry antibiotic resistant genes renders 
the once infected bacterium susceptible to antibiotics to which the 
plasmid containing bacterium expressed resistance. Once the plasmid 
is eliminated, the infection can be treated with commonly available 
antibiotics which are inexpensive and safe.  This new perspective makes 
“old” antibiotics useful for treatment of antibiotic resistant infections 
currently resistant due the presence of plasmids that carry antibiotic 
resistant genes. 
Although the phenothiazine promethazine was initially selected and 
much studied for its in vitro antiplasmid effects because this compound 
is widely used in clinical practice and there  are  no contraindications 
when used in combination with other therapeutic compounds, 
other phenothiazines have been studied for potential anti-plasmid 
properties and some have been shown to express these properties in 
vivo. This review will discuss the development of phenothiazines for 
plasmid elimination for clinical use. During the last four decades the 
frequency of antibiotic resistant infections has continued to escalate. 
Due to this, many antibacterial chemotherapeutics are deemed to be 
ineffective globally and this, according to the recent WHO report [1] 
and presents a serious health problem that affects all countries of the 
world regardless of economic status (add new reference from the WHO 
published two weeks ago) There is thus a recognised urgent need for 
effective treatment alternatives for antibiotic resistant and multidrug 
resistant bacterial pathogens. In the herein review, the focus is on 
one of the mechanisms involved in multi-drug resistance of bacteria, 
namely, the presence of plasmids within the bacterial pathogen which 
carry antibiotic resistant genes that result in the resistance phenotype 
of bacteria. The mechanisms involved in plasmid replication and 
opportunity to block the plasmid replication in vitro and in vivo are 
mainstays of this review. Discussion of different resistance mechanism 
resulting from antibiotic resistance genes carried by the plasmids, e.g., 
antibiotic inactivating enzymes, membrane permeability or drug efflux, 
etc., are  excluded from this short review .
Plasmids are extra-chromosomal self-transmissible DNA elements 
in prokaryotes and some eukaryotic cells. The most important functions 
of plasmids are related to antibiotic resistance, virulence, metabolic 
functions of pathogenic and commensal bacteria. The intracellular 
replication of bacterial chromosome and plasmids are basically different 
as it was first shown by Jacob et al. [2]. 
Plasmids are responsible for the self-transmissible antibiotic 
resistance of bacteria in nature and some of the bacterial plasmids are 
responsible for encoding virulence factors (from Bacillus anthracis 
to Mycobacteria) including tumorigenesis mediated by IV secretion 
systems, TGF etc in humans e.g Bartonella henselae, B. quintana, 
Helicobacter pylori and plants e.g. Agrobacterium tumefaciens [3]. A 
minireview was published by Nóra Gyémánt et al. [3].
Gene mediated metabolic effects of plasmids such as fermentation 
of sugars, nitrogen fixation in plants, haemolytic effects, etc., are 
also known for particular plasmids. Other important functions of 
specific plasmids are the coding for virulence factors (bacteriocins, 
haemolysins, toxins, etc.) that are responsible for the pathogenicity of 
Gram negative and Gram positive bacterial species. Tumor induction 
in man by Helicobacter pylori carrying genes that promote damage 
and inflammatory processes are well known and analogous to tumor 
induction in plants by plasmid carrying Agrobacterium or nitrogen 
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fixation Rhizobium.  Due to the spreading of antibiotic resistance, new 
compounds with antibiotic effects are urgently needed against common 
bacterial infections and tuberculosis as well As an alternative solution 
to combat plasmid mediated multidrug resistance of bacteria that 
cause serious infections and are therapeutically problematic, and often 
untreatable –we must find drugs that target plasmids. These we term 
antiplasmid compounds. The process by which antiplasmid compounds 
may effectively work is termed plasmid elimination.
At first, plasmids carrying antibiotic resistant genes were eliminated 
by acridines and ethidium bromide and phenothiazines in vitro. 
However, because these compounds are well known mutagens, they 
are excluded from in vivo use. In this review, the antiplasmid activity 
of phenothiazine drugs that are used in clinical practice every day- 
because of their known property to intercalate to DNA much in the 
same manner as ethidium bromide and acridines- we have studied 
these compounds for potential antiplasmid effects [4-6]. During these 
studies, it was interesting to note that the growth of various Gram 
positive and Gram negative bacteria were also inhibited by several 
phenothiazines e.g chlorpromazine, levo-mepromazine, diethazine 
and promethazine both in vitro and in vivo [6]. The bactericidal effect 
was also shown on M. tuberculosis at 50 μg/ml; total destruction of the 
organism and loss of acid fastness in part of the cells were shown at 300 
μg/ml phenothiazines [7]. Preliminary studies in mouse experiments 
had shown that the phenothiazine derivatives were moderately effective 
by comparing the mean survival time of M. tuberculosis infected mice. 
Mean survival times of the experimentally infected mice with M. 
tuberculosis No. 23296 were found to be between 45 ± 11 and 48 ± 12 
days. 
The plasmid elimination effect of ethidium bromide, acridine 
orange and widely used medicines such as the antihistaminic 
phenothiazine promethazine Pipolphen) were compared [4-6]. In 
those experiments, chlorpromazine was found to be more effective than 
the acridines. For plasmid elimination we applied tricyclic compounds 
phenothiazines which were not mutagenic in vitro by the direct Ames 
test [8] and hence if effective, could be considered for in vivo human 
use.  Of major importance is that these phenothiazine compounds were 
subsequently shown to possess antimutagenic properties. This was the 
beginning of a series of experiments in the direction of rational drug 
design applicable for elimination of antibiotic resistance- and other 
plasmids for possible use in the medical practice to treat antibiotic 
resistant infections or to produce plasmid free bacteria for basic 
biotechnology free of any mutagenic effects. Theoretically, antiplasmid 
compounds and antibiotics could have synergistic effects and could be 
recommended for the treatment of polyresistant infections without the 
risk of mutagenic effects.
Plasmid Curing Experiments In Vitro
Three phenothiazines such as promezthazine, chlorpromazine, 
levopromazine exerted a bacteriostatic, antiproliferative effect on Gram 
positive, Mycobacterium tuberculosis HRV37 bacteria at 10-60 μg/ml, 
and on Gram negative bacteria at 130-180 μg/ml concentration. Of the 
three compounds, chlorpromazine had a marked bactericidal effect on 
cultures of Bacillus anthracis growing in minimal medium. In addition, 
chlorpromazine had a significant bactericidal effect on resting cells of 
Escherichia coli suspended in saline. Pseudomonas aeruginosa however, 
was found to be resistant to phenothiazines. Experiments failed to 
derive phenothiazine resistant mutants from the highly sensitive B. 
anthracis. 
An effective plasmid carrying R-factor elimination was observed 
at a chlorpromazine concentration of 50 μg/ml; the dose somewhat 
reduced the growth rate of multiple resistant E. coli in broth culture [5]. 
In these experiments we determine the effective phenothiazine 
structures responsible for F’lac plasmid elimination [9]. In another 
experiment, the inhibition of conjugation, the horizontal R-plasmid 
transfer from one cell to another was investigated in the presence 
of chlorpromazine derivatives. Plasmid-curing effect on different 
compatibility groups of the R-plasmids of E. coli was different [10-14].
Two metabolic derivatives of chlorpromazine, the chlorpromazine 
sulphoxide and 7,8-dioxochlorpromazine had no plasmid 
curing effect nor did methylene blue. However amitriptyline, 
7,8-dioxochlorpromazine and acridine orange were inhibitors of the 
conjugal transfer of the resistance plasmid, R-144, whilst methylene 
blue, chlorpromazine sulphoxide, and imipramine had only slight 
effects on the horizontal plasmid transfer in vitro. We were therefore 
unable to demonstrate a simple correlation between curing ability 
and. inhibition of plasmid transfer amongst the psychoactive drugs 
tested. A mechanism of plasmid curing by surface action of the 
drugs was suggested as an alternative to the direct intercalation of the 
drugs into plasmid DNA. Furthermore it is known that acridines and 
chlorpromazine are able to intercalate into DNA in vitro. Consequently, 
as previously suggested [11-13], the mechanism of plasmid curing by 
phenothiazines might be based on an acridine-like intercalation into 
DNA and retransfer of the eliminated plasmids into the plasmidless 
daughter cells both in vitro and in vivo. The partitioning of plasmid into 
daughter cells was simultaneously blocked by inhibiting the septum 
formation in the dividing bacteria forming filaments in the culture and 
the intercalation were essential for the effective plasmid elimination at 
“sub growth inhibitory” doses. The inhibition of plasmid replication, 
partitioning and conjugal transfer of plasmid replication are essential 
requirements for in vitro and in vivo plasmid elimination. The procedure 
did not affect chromosomal replication;   however, inhibition of DNA-
gyrase was shown. The curing effect was correlation of to the super-
delocalizational ability of pi-electrons on the C-8, C-9b and N-atoms of 
phenothiazines [14-18].
Different kinds of plasmids were eliminated form different bacteria 
with phenothiazines and coordination complexes e.g., multiple 
antibiotic resistance, haemolysin B, colicine, and F’lac plasmid (Table 1) 
of E. coli, calcium -binding protein of Y. enterocolitica, tumor inducing 
plasmid of A. tumefaciens,  and nitrogen fixation encoding plasmid 
from Rhizobium [6].
An example of the plasmid curing effect by a phenothiazine is 
presented by (Figure 1). Bacterial cells that produce dark blue colonies 
on EMB agar are cells that contain the F’lac plasmid. However when the 
F’lac plasmid carrying bacterial cells were cultured in the presence of a 
promethazine at sub- inhibitory concentrations  for 20-24 hrs, the F’lac 
plasmid was eliminated from the fraction of the initial cell population 
and these formed pink colonies on the EMB agar plate [9].
Bacterial species Elimination of
Acinetobacter anitratus antibiotic resistance
Agrobacterium tumefaciens tumor inducing ability in plants
Escherichia coli antibiotic resistance and haemolysin B
Escherichia coli lactose fermentation
Staphylococcus aureus antibiotic resistance
Yersinia pseudotuberculosis antibiotic resistance
Yersinia enterocolitica virulence
Rhizobium meliloti nodule formation, N-fixation in plants
Table 1: Results of plasmid elimination in some bacterial species.
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 The plasmid curing effect of various compounds was dependent 
on the applied concentrations of curing compounds; pH and the 
incubation times.
It was interesting for us to note that different psychopharmacons 
with tricyclic structures had similar antibacterial effects on bacteria 
and plasmid replication. Some modification in chemical structures of 
phenothiazines (e.g.sulphoxide) resulted in the loss of plasmid curing 
effects. However when some naturally occurring “psychopharmacons 
or pain killers” e.g cannabis derivatives were studied, the hallucinogenic 
cannabinols did not affect plasmid replication and bacterial growth. 
Only the non-hallucinogenic terahydrocannabiolic acid was able to 
eliminate the bacterial plasmids. This compound had no effect on the 
CNS, and had very slight antibacterial effects. Tetrahydrocannabidiolic 
acid was the only agent that expressed plasmid curing effects [15]. Some 
charge transfer complex formation with the sub-molecular interactions 
were shown to be responsible for inhibition of plasmid replication 
[16-18]. As a result of our in vitro studies, acridines, ethidium, 
phenothiazines compounds, proton pump inhibitor trifluoromethyl-
ketones were shown to be effective in plasmid elimination of bacteria 
in vitro. But because acridines and ethidium are well known mutagens, 
these compounds would exert harmful side-effects on the host, and 
therefore these are excluded for their application in vivo. Conversely, 
certain medicines, e.g., tranquilisers and antidepressants used in 
everyday medical practice exert a similar antiplasmid effect similar 
to that of acridine in vitro. However the phenothiazines studied were 
not mutagenic and their copper, palladium and gold coordination 
complexes had a remarkable anti-mutagenic effectiveness [8] and 
antiplasmid effects [13] by shielding DNA base pairs. 
The structure activity correlation was evaluated in a series of 
in vitro experiments. The pi-electron structure of each compound 
was determined by the Hückel method, and its correlation with 
the antiplasmid effect was studied by quantitative structure activity 
relationship (QSAR) multiregression analysis [11,13,17]. We found 
that the antiplasmid effect of different ring substituted phenothiazines 
correlates with the super-delocalization of the pi-electrons on atoms 
C-8, C-9b and N-10 of the phenothiazines [18,19].
 On the basis of the found correlations, some phenothiazine and 
new anthryl- and phenanthril- compounds were synthetised with 
antiplasmid activity [19,20]. Phenothiazines and structurally related 
drugs were found effective in eliminating various bacterial plasmids 
[9,21]. Charge transfer complex formation between chlorpromazine and 
xanthine dyes with different electron acceptor activities (e.g. fluorescein, 
eosin, erythrosine and rose-bengal) was detected by differential 
spectrophotometry. Charge transfer complexes were formed between 
the strong electron acceptor rose-bengal and various tricyclic drugs as 
well. On the basis of the wavelength shift, the binding energies of drugs 
and dyes were estimated. Drugs with binding energies in the range of 
0.23-2.31 kcal/mol can inactivate plasmid replication systems [15]. A 
serendipitous discovery led to studies on drugs affecting the central 
nervous system which also affect the expression of extra-chromosomal 
plasmids in bacteria. The drugs have a well-defined chemical structure, 
related electrochemical structures and tranquillizing effect in humans. 
Although most of the tricyclic drugs were unable to bind covalently to 
target cells in living systems, promazine was found to from complexes 
with various compounds, e.g., membranes and nucleic acids [2,3,11].
Tricyclic drugs interfere with energy dependent gyrase activity and 
promote the relaxation of plasmid DNA, resulting in a cessation in the 
R plasmid-gene expression and block plasmid replication. These results 
provide insight into the chemical structures connected with significant 
specific antimicrobial, so called antiplasmid effects [8,14].
 A special complex formation was found with the covalently closed 
circular form of plasmid DNA, where GC rich regions of plasmid DNA 
have higher affinity for antiplasmid phenothiazines than adenine-
thymine rich regions of plasmid DNA. Because the G-C rich regions 
have a special role in the DNA stability via three hydrogen bonds, it 
was supposed that these regions could have a key role in the plasmid 
stability and replication [17,18].
Plasmid DNA becomes more rigid due to the intercalated 
phenothiazine molecules and strand breaks occur that lead to the 
formation of non-replicative forms open, circular or linear derivatives 
of CCC form (called covalently closed circular DNA). It is known that 
open circular forms or linear forms of CCC form of plasmid DNA 
cannot start to replicate from the origin of the promoter region due to 
the relaxed form of plasmid DNA [8,16]. Based on these observations 
new anthril compounds were synthetized [19].
It was surprising that some natural compounds isolated from 
essential oils of the peppermint oil exhibited antimicrobial and 
antiplasmid activities. The antiplasmid compounds were isolated 
and identified as menthol [22]. Their effect was comparable to the 
promethazine in vitro. 
There are a number of pharmacologically active tricyclic 
compounds, many of which are in regular clinical use. Some of them 
have been demonstrated to exhibit various antimicrobial activities. They 
inhibit the growth of pathogenic bacteria, causing a general increase 
in membrane permeability, have antibacterial effects on Salmonella, 
Staphylococcus Escherichia coli and Yersinia enterocolitica cells 
[6,18,23,24]. It was shown that phenothiazines exhibited antibacterial 
affect in vitro and in vivo as well [5,6].
The role of charge distribution on the phenothiazines in the 
antiplasmid and antiviral effects was compared. The main aim was to 
design drugs without effects on the central nervous system – and this 
may open up a new way in the experimental chemotherapy. 
 
Figure 1:  Elimination of F’lac plasmid from lactose negative E.coli.  The 
F’lac operon was deleted by mutation and the F’lac plasmid was introduced 
into cells that was responsible for lactose fermentation by these cells. 
These cells F’lac cells produce dark blue colonies on EMB agar. However 
when the cells were cultured in the presence of promethazine at sub- 
inhibitory concentrations  for 20-24 hrs, the plasmid was eliminated from 
the fraction of the cell population and these cells  formed pink colonies on 
the EMB agar plate [9].
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The inhibition of plasmid replication and transfer can be the 
theoretical basis for decrease of bacterial plasmid replication in nature 
as well, where the gram negative bacteria can mediate the transmission 
of various plasmids in the nature. In this aspect there is a certain 
similarity between plasmids and viruses [18].
In Vivo Experiments for Plasmid Elimination
Before the introduction of plasmid curing in vivo, the phenothiazine 
compounds were selected and basic clinical investigations were 
performed e.g., the antibiotic sensitivity of individual bacteria from 
the urine of non-treated and treated patients were compared. In these 
experiments the urine or other biological samples (pus) were serially 
diluted and 100 μl of each dilutions were plated to nutrient agar and 
the plates were then incubated at 37°C to allow the growth a visible 
colony from each bacterial cell. The colonies grown on the master 
plates were transferred to antibiotic containing nutrient agar by 
using the Lederberg replica plating transfer method [25] and plasmid 
elimination from specific colonies readily demonstrated with clinical 
isolates from non-treated patients and patients treated with antibiotics 
plus phenothiazines [25-27]. These results gave rise to the possibility 
of a new type of combination therapy for antibiotic resistant bacterial 
infections mediated by then presence of plasmids carrying antibiotic 
resistant genes; the combination of traditional antibiotics with 
antiplasmid phenothiazines.
The antiplasmid action of phenothiazine and structurally related 
compounds was shown by elimination on the model F’lac plasmid of 
E. coli in model experiments. The first studies of successful plasmid 
elimination by promethazine in human patients were described in 
1981-1982 [26-28].
In our former experiments, the conditions for plasmid eliminations 
were defined. For studies investigating the in vivo antiplasmid effects of 
a phenothiazine, the phenothiazine promethazine was selected because 
of its wide and safe use in everyday medical practice. This phenothiazine 
antihistamine and antiemetic has no remarkable side effects on the 
central nervous system as a consequence of symmetric pi-electron 
distribution in the skeleton of the phenothiazine. This phenothiazine 
was used to potentiate the antimicrobial effects of different antibiotics 
in various urogenital clinical infections in the Clinic of General 
Surgery at the Department of Nephrology, at University of Szeged [28]. 
Promethazine, - a phenothiazine-derivative – was given to patients 
presenting with a urogenital infection. This treatment resulted in the 
pathogenic bacteria in the urine to become sensitive to gentamicin 
and some other antibiotics to which they had been resistant before the 
administration of promethazine. 
 According to the phage-type, the bacteria before and after treatment 
with Pipolphen belonged to the same strain [26-28]. In addition to 
the R plasmid elimination, synergism between promethazine and 
gentamicin was also shown. Due to these results, we supposed that 
the membrane permeability of gentamicin could be enhanced by 
the presence of promethazine and Promethazine (Pipolphen) was 
successfully applied in the clinical practice with 22 patients presenting 
with urogenital bacterial infections. 
The pathogen was isolated from the first urine sample of the patients 
and the antibiotic sensitivity was determined. From the patients, 22 
samples yielded resistant pathogens to 7 different antibiotics. 
Of the 22 patients, 14 stayed in the clinic for 17 days and the patient’s 
urines were checked continuously every day for bacteria and the 
bacteria isolated were studies resistance toe gentamycin resistance. After 
7 days of treatment all the patients were cured from the infection and 
recurrent infections were not observed. The mechanism of synergistic 
action of the drug interaction on cell membrane permeability was 
not studied in detail, but the disappearance of clinical symptoms and 
bacteriuria caused by gentamycin resistant Gram negative pathogens 
(E. coli, Klebsiella, Acinetobacter) was established  [26-28].
In Vivo Studies in Pediatric and Adult Patients
Indeed tricyclic psychopharmacons contain not only a wide 
spectrum of agents that differ chemically and pharmacologically, but 
also in terms of interaction with various macromolecules of different 
cells. Among the well known phenothiazines, promethazine has been 
the most extensively studied. In a series of investigations promethazine 
has been administered to pregnant women for its antiemetic effect. 
Finally, the effects of promethazine were studied in forty children 
with frequently recurring pyelonephritis aged 9.9 ± 4.2 years in the 
Pediatric Clinic at the Department of Nephrology at University of 
Szeged [29]. No significant difference in age and sex was between the 
3 groups. None of the cases involved urological abnormalities. The 
patients were divided in three groups for the treatments. The results of 
three methods of treatment were compared: 
For the in vivo studies we had 3 groups of patients.
 In group 1 for combination therapy 10 children were given a 
combination of gentamycin and promethazine for 7 or 10 days. The 
daily dose of promethazine was 2 mg/kg orally, divided into two doses 
on days 1 and 2, and 1 mg/kg in one dose for the following 5 days. 
Gentamycin was administered i.m. in a daily dose of 4 mg/kg in two 
divided doses for the following (Group 1). The bacterial infections were 
successfully cured.
In the Gentamycin control group 11 patients received gentamycin 
treatment alone (i.m.). alone in the same dosage as in Group 1 for 10 
days (Group 2). 
In Group 3, 19 children received long term antibiotic prophylaxis 
with episodes of intensive treatments for recurrence for two weeks in 
a full dose of antibiotics according to the antibiotic susceptibility test 
(Group 3) were on long-term traditional oral antibiotic prophylaxis 
(5.6 ±2.1 years) with episodes of intensive treatment of recurrences. The 
number of recurrences in Group 1 was 3. 
The number of recurrences in Group 2 was 27 during the 3 years: 
new scars were not observed in any of the patients from this group.
In a 3-year follow-up period, the number of pyelonephritis 
recurrences was significantly lower in Group 1 than in Groups 2 and 3. 
In the 3rd group, six out of 19 children had renal scarring. The authors 
suggest a synergistic effect between gentamycin and promethazine 
therapy. Promethazine increases antibiotic sensitivity, which could 
contribute to the elimination of recurring urinary tract infections 
[28,29].
In previous studies we reported that promethazine and other 
phenothiazines are able to eliminate the antibiotic resistance plasmid 
of E. coli in vitro and in vivo [23-26]. The antibiotic resistance plasmids 
allow the multiplication of bacteria in the presence of antibiotics 
which makes the antibiotic treatment insufficient. Plasmid curing was 
supposed to improve the opportunities of chemotherapy. 
The practical importance of plasmid elimination in antimicrobial 
chemotherapy was supported by the studies where the plasmid curing 
effects of promethazine was induced in mixed bacterial cultures e.g. in 
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the presence of S. epidermidis and B. cereus. The interactions between 
coexisting bacterial species did not reduce the frequency of plasmid 
curing by promethazine in mixed cultures with S. epidermidis or B. 
cereus in vitro [30].
 In conclusion, we have demonstrated the role of plasmid elimination 
with combination   chemotherapy by sensitizing the bacterial cells 
to antibiotics. Elevating the penetration of somle antibiotics into 
bacterial cells also can be a component to be considered in the rational 
drug design against multidrug resistant bacterial infections by the 
simultaneous application of antiplasmid compounds and antibiotics 
[31]. 
Antiplasmid effect of structurally similar maproptiline, 
amitriptilline to phenothiazines has also been shown in the patients. 
Based on on-going research in vivo studies, some new results will be 
reported in a forthcoming publication together with implication of 
combinations of antiplasmid compounds with antibiotics to improve 
the therapy of various acute and chronic bacterial infections. 
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